Jannie Oosthuizen
Fortuna: 3 M $ al 31/05/2026
Fortuna: 3 M $ al 31/05/2026
Jannie Oosthuizen currently holds the position of EVP, President-Oncology & MSD International at Merck & Co., Inc. starting in 2026.
Jannie also serves as President at Merck Human Health US since 2022.
Additionally, Jannie is Manager-Legal & Human Resources at Esor Ltd. Mr. Oosthuizen completed graduate studies at North-West University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 05/05/2026 | 21.895 ( 0 % ) | 3 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2021 |
| ESOR LIMITED | Oficial de Recursos Humanos | - |
Merck Human Health US | Presidente | 01/01/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Merck Human Health US | |
North-West University
North-West University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Esor Ltd.
Esor Ltd. Engineering & ConstructionIndustrial Services Provides civil engineering and construction services | Industrial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.